StockData
Petros Pharmaceuticals, Inc. logo

Petros Pharmaceuticals, Inc. (PTPI) stock

PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$0.00+0.00 (+5.56%)

Close on Oct 19, 2026Market cap $135.07KP/E –Yield –

Petros Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Petros Pharmaceuticals's enterprise value was -$3.37M on Oct 19, 2026, against -$6.53M a year earlier. Over the last 5 years it ranged from -$8.87M to $25.12M, with a median of $405.27K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026-$3.37M–
2025Dec 31, 2025-$5.73M-201.2%
2024Dec 31, 2024$5.66M–
2023Dec 29, 2023-$7.73M-422.2%
2022Dec 30, 2022$2.40M-90.4%
2021Dec 31, 2021$25.12M–

More Petros Pharmaceuticals figures

See a number that looks wrong?